Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations

被引：0

作者：

Mueller, Martin C. ^{[1
]}

Cortes, Jorge ^{[2
]}

Kim, Dong-Wook ^{[3
]}

Druker, Brian J. ^{[4
]}

Erben, Philipp ^{[1
]}

Pasquini, Ricardo ^{[5
]}

Hughes, Timothy P. ^{[6
]}

Matloub, Yousif ^{[7
]}

Ploughman, Lynn ^{[7
]}

Hochhaus, Andreas ^{[1
]}

机构：

[1] Univ Heidelberg, Med Fak Mannheim, D-6800 Mannheim, Germany

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] St Marys Hosp, Div Hematol, Seoul, South Korea

[4] Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA

[5] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil

[6] Inst Med & Vet Sci, Adelaide, SA 5000, Australia

[7] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：171 / 172

页数：2